Tandem + DexcomTrusted Partners in Diabetes Management
Dexcom G7 continuous glucose monitoring (CGM)* Systems integrate with both the Tandem Mobi system and t:slim X2 insulin pump. Integrating Dexcom G7 CGM Systems with Tandem Diabetes Care insulin pumps provides exceptional accuracy1 for optimized insulin delivery.
Helping to take the hassle out of sensor wear.
Simple Auto-Applicator
A one-touch applicator provides easy insertion. The absence of a visible needle can help increase comfort.
Faster Sensor Startup
Minimize downtime between sensor sessions for more consistent day-to-day glucose management.†
Goodbye Fingersticks
For calibration or mealtime dosing, when our insulin pumps are paired with Dexcom G7 CGM Systems.‡
More Days. Fewer Swaps.
Available in 10-day and 15-day wear options, Dexcom G7 CGM Systems are designed to last longer and help reduce how often replacements are needed.
Best Glucose Control
People who combine CGM with automated insulin delivery, such as Control-IQ+ technology, have the best overall glucose control versus multiple daily injections or standard insulin pump therapy.1
Learn about your coverage for Tandem and Dexcom integration.
* CGM sold separately.
† Faster claim based on two-hour warmup time with the Dexcom G6 sensor vs. 30-minute warmup time with Dexcom G7 CGM Systems.
‡ If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Reference
1. Nørgaard K, Ranjan AG, Laugesen C, et al. Glucose Monitoring Metrics in Individuals with Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study. Diabetes Care. 2023;dc231137. doi: 10.2337/dc23-1137.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.